Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms

Abstract

Basal telomerase activity is dependent on expression of the hTERT and hTR genes and upregulation of telomerase gene expression is associated with tumour development. It is therefore possible that signal transduction pathways involved in tumour development and features of the tumour environment itself may influence telomerase gene regulation. The majority of solid tumours contain regions of hypoxia and it has recently been demonstrated that hypoxia can increase telomerase activity by mechanisms that are still poorly defined. Here, we show that hypoxia induces the transcriptional activity of both hTR and hTERT gene promoters. While endogenous hTR expression is regulated at the transcriptional level, hTERT is subject to regulation by alternative splicing under hypoxic conditions, which involves a switch in the splice pattern in favour of the active variant. Furthermore, analysis of the chromatin landscape of the telomerase promoters reveals dynamic recruitment of a transcriptional complex involving the hypoxia-inducible factor-1 transcription factor, p300, RNA polymerase II and TFIIB, to both promoters during hypoxia, which traffics along and remains associated with the hTERT gene as transcription proceeds. These studies show that hTERT and hTR are subject to similar controls under hypoxia and highlight the rapid and dynamic regulation of the telomerase genes in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 6
Figure 4
Figure 5

Similar content being viewed by others

References

  • Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA et al. (1996). Proc Natl Acad Sci USA 93: 12969–12973.

  • Ashcroft M, Bardos JI . (2004). Bioessays 26: 262–269.

  • Atkinson SP, Hoare SF, Glasspool RM, Keith WN . (2005). Canc Res (in press).

  • Bilsland AE, Anderson CJ, Fletcher-Monaghan AJ, McGregor F, Evans TRJ, Ganly I et al. (2003). Oncogene 22: 370–380.

  • Blasco MA, Hahn WC . (2003). Trends Cell Biol 13: 289–294.

  • Chen H, Hahn S . (2004). Cell 119: 169–180.

  • Elsby LM, Roberts SGE . (2004). Biochem Soc Trans 32: 1098–1099.

  • Forsythe JA, Jiang B, Iyer NV, Agani F, Leung SW, Koos RD et al. (1996). Mol Cell Biol 16: 4604–4613.

  • Freedman SJ, Sun ZJ, Poy F, Kung AL, Livingston DM, Wagner G et al. (2002). Proc Natl Acad Sci USA 99: 5367–5372.

  • Gomez-Roman N, Grandori C, Eisenman RN, White RJ . (2003). Nature 421: 290–294.

  • Gorbunova V, Seluanov A, Pereira-Smith OM . (2002). J Biol Chem 277: 38540–38549.

  • Graven KK, Troxler RF, Kornfeld H, Panchenko MV, Farber HW . (1994). J Biol Chem 269: 24446–24453.

  • Hahn S . (2004). Nat Struct Mol Biol 11: 394–403.

  • Hashimoto Y, Zhang C, Kawauchi J, Imoto I, Adachi MT, Inazawa J et al. (2002). Nucleic Acid Res 30: 2398–2406.

  • Hockel M, Vaupel P . (2001). J Natl Cancer Inst 93: 266–276.

  • Kallio PJ, Okamoto K, O’Brien S, Carrero P, Makino Y, Tanaka H et al. (1998). EMBO J 17: 6573–6586.

  • Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, Keese PK et al. (1997). Hum Mol Genet 6: 2011–2019.

  • Kornblihtt AR, De La Mata M, Fededa JP, Munoz MJ, Nogues G . (2004). RNA 10: 1489–1498.

  • Kung AL, Wang S, Klco JM, Kaelin Jr WG, Livingston DM . (2000). Nat Med 6: 1335–1340.

  • Luiten RM, Pene J, Yssel H, Spits H . (2003). Blood 101: 4512–4519.

  • Minamino T, Mitsialis SA, Kourembanas S . (2001). Mol Cell Biol 21: 3336–3342.

  • Misteli TaSDL . (1999). Mol Cell 3: 697–705.

  • Munch C, Zhu B, Leven A, Stamm S, Einkorn H, Schwalenstocker B et al. (2003). J Neurosci Res 71: 819–825.

  • Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K . (2004). Mol Cell Biol 24: 6076–6083.

  • Plumb JA, Bilsland A, Kakani R, Zhao J, Glasspool RM, Knox RJ et al. (2001). Oncogene 20: 7797–7803.

  • Reynolds TY, Rockwell S, Glazer PM . (1996). Cancer Res 56: 5754–5757.

  • Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee A, Yoshida H et al. (2004). Cancer Res 64: 5943–5947.

  • Seimiya H, Tanji M, Oh-hara T, Tomida A, Naasani I, Tsuro T . (1999). Biochem Biophys Res Commun 260: 365–370.

  • Shi Y, Sawada J, Sui G, Affar EB, Whetstine JR, Lan F et al. (2003). Nature 422: 735–738.

  • Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . (1998). Cancer Res 58: 4168–4172.

  • Yatabe N, Kyo S, Maida Y, Nishi H, Nakamura M, Kanaya T et al. (2004). Oncogene 23: 3708–3715.

  • Zaffaroni N, Porta CD, Villa R, Botti C, Buglioni S, Mottolese M et al. (2002). J Pathol 198: 37–46.

  • Zhang C, Dowd DR, Staal A, Gu C, Lian JB, van Wijnen AJ et al. (2003a). J Biol Chem 278: 35325–35336.

  • Zhang L, Johnson M, Le KH, Sato M, Ilagan R, Iyer M et al. (2003b). Cancer Res 63: 4552–4560.

Download references

Acknowledgements

Research is supported by Cancer Research UK, Glasgow University and European Community Grant LSHC-CT-2004–502943.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W N Keith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, C., Hoare, S., Ashcroft, M. et al. Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 25, 61–69 (2006). https://doi.org/10.1038/sj.onc.1209011

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209011

Keywords

This article is cited by

Search

Quick links